» Articles » PMID: 28105165

The Value of 64-slice Spiral CT Perfusion Imaging in the Treatment of Liver Cancer with Argon-helium Cryoablation

Overview
Journal Oncol Lett
Specialty Oncology
Date 2017 Jan 21
PMID 28105165
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

We analyzed the effectiveness of using 64-slice spiral computed tomography (CT) and perfusion imaging to guide argon-helium cryoablation treatment of liver cancer. In total, 60 cases of advanced hepatocellular carcinoma before surgery treated with argon-helium cryoablation were inlcuded in the present study. Retrospective summary of the 60 cases of metaphase and advanced liver cancer were used as the control group. The control group were treated using cryoablation with argon-helium knife. We used enhanced scanning with 64-slice spiral CT to define the extent of their lesions and prepared a plan of percutaneous cryoablation for the treatment. Intraoperatively, we used the dynamics of CT perfusion imaging to observe the frozen ablation range and decreased the rate of complications. After surgery, the patients were followed-up regularly by 64-slice CT. We used conventional X-ray, CT and magnetic resonance imaging (MRI) for pre-operative lateralization. Intraoperative X-ray or ultrasound guidance and follow-up with CT or MTI were added to determine the clinical effectiveness and prognosis. The results showed that the total effective rate was improved significantly and incidence rate of overall complications decreased markedly in the observation group. Following treatment, AFP decreased significantly while the total freezing area and time were reduced significantly. The median survival time was increased significantly in the observation group. The numeric values of hepatic arterial perfusion, portal vein perfusion and hepatic arterial perfusion index were all markedly lowered after treatment. Differences were statistically significant (P<0.05). In conclusion, the use of 64-slice spiral CT perfusion imaging may considerably improve the effects of liver cancer treatment using the argon-helium cryoablation. It extended the survival time and reduced complications.

Citing Articles

Current Imaging Diagnosis of Hepatocellular Carcinoma.

Chartampilas E, Rafailidis V, Georgopoulou V, Kalarakis G, Hatzidakis A, Prassopoulos P Cancers (Basel). 2022; 14(16).

PMID: 36010991 PMC: 9406360. DOI: 10.3390/cancers14163997.


Microwave Ablation of Liver, Kidney and Lung Lesions: One-Month Response and Manufacturer's Charts' Reliability in Clinical Practice.

Frandon J, Akessoul P, Kammoun T, Dabli D, de Forges H, Beregi J Sensors (Basel). 2022; 22(11).

PMID: 35684594 PMC: 9182645. DOI: 10.3390/s22113973.


Recent progress in cryoablation cancer therapy and nanoparticles mediated cryoablation.

Kwak K, Yu B, Lewandowski R, Kim D Theranostics. 2022; 12(5):2175-2204.

PMID: 35265206 PMC: 8899563. DOI: 10.7150/thno.67530.


Intelligent Algorithm-Based Multislice Spiral Computed Tomography to Diagnose Coronary Heart Disease.

Tan S, Xu Z Comput Math Methods Med. 2022; 2022:4900803.

PMID: 35069783 PMC: 8776441. DOI: 10.1155/2022/4900803.


Liquid Nitrogen-Based Cryoablation in In Vivo Porcine Tissue: A Pilot Study.

Chang D, Mohan P, Amin A, Garcia-Buitrago M, Rodriguez J, Peaden R Asian Pac J Cancer Prev. 2020; 21(10):3069-3075.

PMID: 33112569 PMC: 7798152. DOI: 10.31557/APJCP.2020.21.10.3069.

References
1.
Wei S, Hao X, Zhan D, Xiong M, Li K, Chen X . Are surgical indications of Barcelona Clinic Liver Cancer staging classification justified?. J Huazhong Univ Sci Technolog Med Sci. 2011; 31(5):637. DOI: 10.1007/s11596-011-0574-1. View

2.
Sabir A, Schor-Bardach R, Wilcox C, Rahmanuddin S, Atkins M, Kruskal J . Perfusion MDCT enables early detection of therapeutic response to antiangiogenic therapy. AJR Am J Roentgenol. 2008; 191(1):133-9. DOI: 10.2214/AJR.07.2848. View

3.
Li J, Zhao D, Jiang H, Huang Y, Li D, Wan Y . Assessment of tumor vascularization with functional computed tomography perfusion imaging in patients with cirrhotic liver disease. Hepatobiliary Pancreat Dis Int. 2011; 10(1):43-9. DOI: 10.1016/s1499-3872(11)60006-4. View

4.
Jain R, Narang J, Schultz L, Scarpace L, Saksena S, Brown S . Permeability estimates in histopathology-proved treatment-induced necrosis using perfusion CT: can these add to other perfusion parameters in differentiating from recurrent/progressive tumors?. AJNR Am J Neuroradiol. 2011; 32(4):658-63. PMC: 7965885. DOI: 10.3174/ajnr.A2378. View

5.
Hao X, Li J, Jiang H, Li D, Ling Z, Xue L . CT assessment of liver hemodynamics in patients with hepatocellular carcinoma after argon-helium cryoablation. Hepatobiliary Pancreat Dis Int. 2013; 12(6):617-21. DOI: 10.1016/s1499-3872(13)60097-1. View